↓ Skip to main content

Prevalence of Significant Genetic Variants in Congenital Long QT Syndrome is Largely Underestimated

Overview of attention for article published in Frontiers in Pharmacology, January 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prevalence of Significant Genetic Variants in Congenital Long QT Syndrome is Largely Underestimated
Published in
Frontiers in Pharmacology, January 2012
DOI 10.3389/fphar.2012.00072
Pubmed ID
Authors

Elena V. Zaklyazminskaya, Hugues Abriel

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 4%
Unknown 23 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 17%
Other 3 13%
Professor 3 13%
Researcher 3 13%
Student > Master 3 13%
Other 5 21%
Unknown 3 13%
Readers by discipline Count As %
Medicine and Dentistry 9 38%
Agricultural and Biological Sciences 5 21%
Biochemistry, Genetics and Molecular Biology 2 8%
Arts and Humanities 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Other 1 4%
Unknown 5 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2015.
All research outputs
#3,414,665
of 25,371,288 outputs
Outputs from Frontiers in Pharmacology
#1,602
of 19,711 outputs
Outputs of similar age
#25,686
of 250,087 outputs
Outputs of similar age from Frontiers in Pharmacology
#22
of 147 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,711 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,087 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 147 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.